These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7581130)

  • 1. Transplantation of G-CSF mobilized allogeneic peripheral blood stem cells in rabbits.
    Gratwohl A; Baldomero H; John L; Gimmi C; Pless M; Tichelli A; Nissen C; Filipowicz A; Speck B
    Bone Marrow Transplant; 1995 Jul; 16(1):63-8. PubMed ID: 7581130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic peripheral blood precursor cell transplants in rabbits.
    Gratwohl A; Baldomero H; John L; Filipowicz A; Tichelli A; Nissen C; Speck B
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S14-8. PubMed ID: 8722327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation.
    Sautois B; Baudoux E; Salmon JP; Michaux S; Schaaf-Lafontaine N; Pereira M; Paulus JM; Fillet G; Beguin Y
    Haematologica; 2001 Nov; 86(11):1209-18. PubMed ID: 11694408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection.
    Vanásek J; Filip S; Medková V; Bláha M; Mericka P; Volenec K
    Bone Marrow Transplant; 1998 Jan; 21(2):123-6. PubMed ID: 9489627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors.
    Körbling M; Chan KW; Anderlini P; Seong D; Durett A; Langlinais A; Przepiorka D; Gajewski J; Miller P; Sundberg J; Alilaen P; Bojko P; Mirza N; Claxton D; van Besien K; Khouri I; Andersson B; Mehra R; Champlin R
    Bone Marrow Transplant; 1996 Nov; 18(5):885-90. PubMed ID: 8932841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
    Hohaus S; Martin H; Wassmann B; Egerer G; Haus U; Färber L; Burger KJ; Goldschmidt H; Hoelzer D; Haas R
    Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
    Hohaus S; Goldschmidt H; Ehrhardt R; Haas R
    Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of pegylated recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor on mobilization of hematopoietic progenitor and stem cells with long-term repopulating ability into peripheral blood in mice.
    Honda K; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M
    Bone Marrow Transplant; 2001 Aug; 28(4):329-34. PubMed ID: 11571503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.
    Patchen ML; Liang J; Vaudrain T; Martin T; Melican D; Zhong S; Stewart M; Quesenberry PJ
    Stem Cells; 1998; 16(3):208-17. PubMed ID: 9617896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
    Cesana C; Carlo-Stella C; Regazzi E; Garau D; Sammarelli G; Caramatti C; Tabilio A; Mangoni L; Rizzoli V
    Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia.
    Andrews RG; Briddell RA; Hill R; Gough M; McNiece IK
    Stem Cells; 1999; 17(4):210-8. PubMed ID: 10437984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation.
    Matsunaga T; Sakamaki S; Kohgo Y; Ohi S; Hirayama Y; Niitsu Y
    Bone Marrow Transplant; 1993 Feb; 11(2):103-8. PubMed ID: 7679596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor.
    Laterveer L; Zijlmans JM; Lindley IJ; Hamilton MS; Willemze R; Fibbe WE
    Exp Hematol; 1996 Oct; 24(12):1387-93. PubMed ID: 8913284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood pressure cells transplants across a major histocompatibility barrier in rabbits: positive effects of a higher number of precursor cells?
    Gratwohl A; Baldomero H; John L; Tichelli A; Filipowicz A; Nissen C; Speck B
    Acta Haematol; 1996; 95(3-4):176-80. PubMed ID: 8677739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.